MedPath

Impact of inflammatory cytokines to CYP3A or OATP1B activities in rheumatoid arthritis patient using endogenous substrate.

Not Applicable
Conditions
rheumatoid arthritis
Registration Number
JPRN-UMIN000034715
Lead Sponsor
Oita University Hospital, Department of Clinical Pharmacy
Brief Summary

37 outpatients with RA were analyzed. OATP1B115 carriers tended to have higher CP-I concentration compared to non-carriers. Plasma CP-I correlated positively with CMPF concentration, but did not correlate with IL-6 or TNF-alpha concentration. Multiple logistic regression analysis by stepwise selection identified plasma CMPF concentration and OATP1B115 allele as significant factors independently affecting plasma CP-I concentration at baseline and at the next visit, respectively.

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up continuing
Sex
All
Target Recruitment
37
Inclusion Criteria

Not provided

Exclusion Criteria

Not applicable

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath